hemiparesis Stroke
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subacute stroke patients: - An unilateral stroke (ischemic or haemorrhagic) confirmed by brain imaging; - Post stroke duration between 6 weeks and 3 months; - Hemiplegic pattern of arm motor impairment with UAT score 1-3; - Age 18 years or more; - Sufficient cognitive level, i.e. being able to understand the questionnaires and measurement instructions. Chronic stroke patients: - An unilateral stroke (ischemic or haemorrhagic) confirmed by brain imaging; - Post-stroke time larger than 12 months; - Hemiplegic pattern of arm motor impairment with UAT score 1-3; - Age 18 years or more; - Sufficient cognitive level, i.e. being able to understand the questionnaires and measurement instructions., Healthy subjects (i.e. therapists): - degree in physiotherapy or occupational therapy; - experience in treatment of patients with central nervous system deficits.
Exclusion criteria
Exclusion criteria: Subacute and chronic stroke patients: - Severe non-stroke related co-morbidity that may interfere with arm-hand function. - Additional complaints that may interfere with the execution of the measurements. - Severe cognitive problems that prevent the patient from understanding the tasks - Spasticity in the affected upper limb, i.e. a Modified Ashworth Scale (MAS) score * 1+. - No informed consent. Healthy subjects (i.e. therapists): - Therapists who are not willing to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Action Research Arm Test (ARAT), gauging patients' arm hand skill capacity, will serve as primary outcome measure in the pilot study. | — |
Secondary
| Measure | Time frame |
|---|---|
| The Fugl-Meyer test (gauging patients' fucntion level), the ABILHAND (gauging patients' perceived skill performance), movement extent (measured by the remote handling concept device) and self-perceived performance of activities trained on by patients (gauged using a visual analogue scale (VAS)) will serve as secundary outcome measures for the pilot study. | — |
Countries
Netherlands